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http://dx.doi.org/10.1016/j.kjms.201
1607-551X/Copyright ª 2014, KaohsiuAbstract The purpose of this study was to determine the role of red cell distribution width
(RDW), neutrophilelymphocyte ratio (NLR), and plateletelymphocyte ratio (PLR) in the diagnostic
phase of acute pulmonary embolism (PE). We screened 248 consecutive patients who were
admitted to the emergency service with PE foremost in the differential diagnosis. Based on spiral
computed chest tomography, the patients were divided into two groups. There were 112
confirmed cases of acute PE and 138 patients without PE. Blood samples were obtained within 2
hours of presentation and before starting any medication. There were no significant differences
between the PE and thenon-PE groupswith respect to sex, age, frequency of disease, serumcreat-
inine, sodium, and potassium (p> 0.05 for all). NLR, RDW, and PLRwere higher in patients with PE
than those without PE. High-sensitivity C-reactive protein, D-dimer, and troponin levels were also
higher in patients with PE. RDW values were positively correlated with troponin levels (rZ 0.147,
pZ 0.021). There were no correlations between RDW and NLR, PLR, or D-dimer. NLR had a highly
positive correlation with PLR (rZ 0.488, p < 0.001). In multivariate logistic regression analysis,
troponin I, D-dimer, high-sensitivity C-reactive protein, and RDW were found to be independent
predictors of PE [odds ratio (95% confidence interval) respectively: 5.208 (2.534e10.704), 1.242
(1.094e1.409), 1.005 (1.000e1.010), 1.175 (1.052e1.312)]. In receiver operating characteristic
analysis of the patients in the study, RDW >18.9 predicted acute PE with a sensitivity of 20.7%
and a specificity of 93.4%. In conclusion, RDW can be considered useful as a diagnostic measure
for patients with suspected acute PE.
Copyright ª 2014, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.eclare no conflicts of interest.
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Acute pulmonary embolism (PE) is a life-threatening and
common cardiopulmonary disease with a mortality rate of
15e20% [1]. It usually arises from a thrombus formed in the
deep venous system of the lower extremities. It can
occlude the pulmonary arterial bed and may lead to a
chronic disabling condition, an acute life-threatening
illness, or even death. As the clinical presentation for
pulmonary embolism is often nonspecific and equivocal,
clinical physicians need to pay much more attention to its
diagnosis [2]. For this reason, it is prudent to pursue a quick
and definitive diagnosis in every suspected case of PE.
Because of its wide availability and ability to directly
visualize thrombus, computed tomography imaging has
become the standard imaging technique for the diagnosis of
acute PE [3]. Routine laboratory testing is not useful in
proving the presence of venous thrombosis or PE, but may
contribute to the evaluation of the differential diagnosis.
The diagnostic work ought to be as noninvasive and cost-
effective as possible in order to minimize health system
expenditures. The utility of plasma measurements of
circulating D-dimer, a specific derivative of cross-linked
fibrin, has been evaluated extensively as a diagnostic test
in suspected PE. The recommended diagnostic pathway for
outpatients with a low or intermediate probability of PE is
to begin by performing a highly sensitive D-dimer assay
[4,5]. Another marker, cardiac troponins, has been evalu-
ated in the setting of acute PE and elevated troponin levels
correlate with electrocardiographic and echocardiographic
findings of right ventricular pressure overload. Elevated
plasma troponin levels have been repeatedly reported as
associated with worse prognosis and increased mortality in
patients with PE [6,7]. Elevated brain natriuretic peptide
has also been shown to be a marker of right ventricular
pressure overload and one of the predictors of adverse
outcome in patients with acute PE [8,9]. Complete blood
count is part of the routine laboratory investigations in
most hospitalized patients.
The red cell distribution width (RDW) is a measurement
that is obtained by automated hematology analyzers. It
reflects the range of the red cell sizes that are measured
within a sample. RDW is strongly associated with prognosis
in cardiopulmonary disorders such as coronary artery dis-
ease (CAD), acute myocardial infarction, acute and chronic
heart failure, and pulmonary hypertension [10e15].
Recently it was shown that an elevated neu-
trophilelymphocyte ratio (NLR) is related to early mortality
in patients with PE [16]. An elevated plateletelymphocyte
ratio (PLR) as a risk factor for arterial obstructive diseases
has been evaluated in some studies. It has been shown that
elevated PLR is a significant independent predictor of long-
term mortality after non-ST elevation myocardial infarction
[17]. Gary et al demonstrated that a PLR > 150 proved to be
at least comparable to a NLR > 3.95, an already established
vascular risk factor, in its association with critical limb
ischemia in patients with peripheral arterial occlusive dis-
ease [18]. However, the diagnostic value of PLR and NLR in
acute PE is unknown. The goal of this study is to investigate
the diagnostic value of RDW, NLR, and PLR, measured on
admission, in patients suspected of having acute PE.Materials and methods
This study was approved by the ethics review board of
Mersin University School of Medicine. In this study, we
retrospectively screened 248 consecutive patients over 18
years who were admitted to hospital with a suspect of PE
between January 2011 and May 2013. Exclusion criteria
were: active or chronic inflammatory or autoimmune dis-
eases; inflammatory rheumatic disease; anemia; clinical
evidence of active infection; active cancer; any hemato-
logical diseases; recent blood transfusion; chronic renal
disease; and history of chronic obstructive pulmonary dis-
ease. According to their spiral computed chest tomography,
the patients were divided into two groups: 112 of them had
acute PE and 138 patients had no PE.Biochemical analysis
Blood samples were obtained within 2 hours of presentation
before starting any medication and were collected in tri-
potassium EDTA tubes. All measurements were performed
30 minutes after blood collection by an automatic blood
counter (A Sysmex XE-2100; Symex, Kobe, Japan). D-Dimer
was measured using Sysmex CA-7000 (Symex), troponin I
was measured using Access 2 Immunoassay System (Beck-
man Coulter Inc., Brea, CA, USA), and high-sensitivity C-
reactive protein (hsCRP) was measured using a BN2 model
nephlometer.Statistical analysis
Continuous variables are given as the mean  standard
deviation; categorical variables were defined as a per-
centage. A value of p < 0.05 was considered significant.
Comparisons between groups were carried out using an
independent-samples t test. Correlation analyses were
performed using the Pearson or Spearman coefficient of
correlation. Multivariate logistic regression analysis was
used to show the independent predictors for PE. The cut-
off levels, sensitivity and specificity values of RDW in PE
patients were determined using MedCalc 12.7.0.1 (MedCalc
Software, Mariakerke, Belgium). A trial version of SPSS 20.0
software was used for basic statistical analysis (Version 20;
SPSS Inc., Chicago, IL, USA).Results
The baseline characteristics of the study participants are
summarized in Table 1. There were no significant differ-
ences between the PE and the non-PE groups with respect
to sex, age, frequency of disease (i.e. diabetes mellitus,
hypertension, smoking, and coronary artery disease), serum
creatinine, sodium, and potassium (p > 0.05 for all). NLR
values were higher in patients with PE than without PE
(6.2  2.9 in the PE group vs. 5.4  3.0 in the non-PE group,
pZ 0.03). RDW and PLR values were also higher in patients
in the PE group compared to the non-PE group (respec-
tively: 15.9  3.8 vs. 14.8  2.2, p Z 0.005 and 210  131
vs. 178  107, p Z 0.03).
Table 1 The baseline clinical and biochemical charac-






Age (y) 59  16 62  15 0.1
Female (%) 55 54 0.4
Creatinine
(mg/dL)
0.93  0.5 0.93  0.2 0.9
Na (mg/dL) 135  4 136  4 0.3
K (mg/dL) 3.7  0.6 3.8  0.7 0.3
AST (U/L) 36  32 37  32 0.7
ALT (U/L) 29  26 32  35 0.4
Hb (mg/dL) 13.3  1.1 13.3  1.2 0.7
RDW (%) 15.9  3.8 14.8  2.2 0.005
NLR 6.2  2.9 5.4  3.0 0.03
PLR 210  131 178  107 0.03
D-Dimer (ng/mL) 3.5  3.0 1.9  2.1 < 0.001
Troponin I
(ng/mL)
1.4  1.9 0.1  0.3 < 0.001
HsCRP (mg/L) 76  74 52  64 0.007
A value of p < 0.05 was accepted as statistically significant.
ALT Z alanine aminotransferase; AST Z aspartate amino-
transferase; Hb Z hemoglobin; hsCRP Z high-sensitivity C-
reactive protein; NLR Z neutrophil lymphocyte ratio;
PE Z pulmonary embolism; PLR Z platelet lymphocyte ratio;
RDW Z red cell distribution width.
Table 3 Logistic regression analysis of risk factors pre-
dicting pulmonary embolism.
Risk factors OR (95% CI) p
Troponin I 5.208 (2.534e10.704) <0.001
D-Dimer 1.242 (1.094e1.409) 0.001
hsCRP 1.005 (1.000e1.010) 0.037
NLR 0.887 (0.780e1.009) 0.068
PLR 0.998 (0.995e1.002) 0.340
RDW 1.175 (1.052e1.312) 0.004
p < 0.05 was accepted as statistically significant.
CI Z confidence interval; hsCRP Z high sensitive C-reactive
protein; NLR Z neutrophil lymphocyte ratio; OR Z odds ratio;
PLR Z platelet lymphocyte ratio; RDW Z red cell distribution
width.
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patients with PE (Table 1). The correlation analysis is shown
in Table 2. RDW values were positively correlated with
troponin levels (r Z 0.147, p Z 0.021). NLR had a highly
positive correlation with PLR (r Z 0.488, p < 0.001). The
troponin levels were positively correlated with D-dimer
levels (r Z 0.231, p < 0.001).
In multivariate logistic regression analysis, troponin I,
D-dimer, hsCRP, and RDW were found to be independent
predictors of PE (Table 3).
In receiver operating characteristic analysis of the pa-
tients in the study, RDW predicted acute PE with a sensi-
tivity of 20.7% and a specificity of 93.4% over 18.9 (Fig. 1).Table 2 The correlation analysis of hematologic parameters w
troponin in all study patients.
hsCRP D-Dimer
hsCRP Pearson correlation 1 0.117
p 0.066
D-Dimer Pearson correlation 0.117 1
p 0.066
Troponin I Pearson correlation 0.092 0.231*
p 0.148 <0.001
RDW Pearson correlation 0.012 0.038
p 0.849 0.557
PLR Pearson correlation 0.057 0.034
p 0.375 0.593
NLR Pearson correlation 0.057 0.012
p 0.371 0.848
* Correlation is significant at the 0.05 level.
NLR Z neutrophil lymphocyte ratio; PLR Z platelet lymphocyte ratioDiscussion
In our study, we found that RDW, NLR, and PLR values in the
PE group were higher than in the non-PE group. In multi-
variate logistic regression analysis, only RDW was found to
be an independent predictor of PE among the hematologi-
cal parameters. Troponin I, HsCRP, and D-dimer were also
found to be independent predictors of PE. We are unaware
of any studies that have looked at the diagnostic value of
RDW in PE. To the best of our knowledge, this is the first
study that specifically evaluates the role of RDW in PE
diagnosis among patients admitted to the emergency ser-
vice suspected of having PE.
RDW is a measure of variability in the size of circulating
erythrocytes, with higher values reflecting greater hetero-
genity in cell sizes (anisocytosis), and it is part of a com-
plete blood count. An increased RDW is usually associated
with ineffective red cell production, such as occurs in iron
deficiency anemia, vitamin B12, and folic acid deficiency,
anemia of chronic disease, and hemoglobinopathies, or red
blood cell destruction in the cases of hemolysis and blood
transfusion [10]. Felker et al have shown that an elevated
RDW is a strong independent predictor of outcome in pa-
tients with chronic heart failure (HF) [19]. Several studiesith high-sensitivity C-reactive protein (hsCRP), D-dimer, and
Troponin I RDW PLR NLR
0.092 0.012 0.057 0.057
0.148 0.849 0.375 0.371
0.231* 0.038 0.034 0.012
<0.001 0.557 0.593 0.848
1 0.147* 0.027 0.028
0.021 0.670 0.665
0.147* 1 0.041 0.028
0.021 0.520 0.662
0.027 0.041 1 0.488*
0.670 0.520 <0.001
0.028 0.028 0.488* 1
0.665 0.662 < 0.001
; RDW Z red cell distribution width.
Figure 1. Receiver operating characteristic curve analysis of
study patients for predicting pulmonary embolism. The area
under the curve is 0.559. Criterion is over 18.9 with 20.7%
sensitivity and 93.4% specificity. Standard error Z 0.0369, 95%
confidence interval Z 0.495e0.622, z statistic Z 1.602,
p Z 0.1091.
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et al conducted a post hoc analysis in the Cholesterol and
Recurrent Events study and demonstrated that baseline
RDW in patients with a history of acute myocardial infarc-
tion without symptomatic HF is an independent predictor of
poor outcomes [12]. These results have been confirmed in
many subsequent studies that indicate that RDW is associ-
ated with adverse outcomes in cardiovascular and non-
cardiovascular disease states. An elevated RDW has been
shown to have an association with death due to cardiac
causes, nonfatal acute myocardial infarction, recent onset
of heart failure, and stroke. These results have been
confirmed in many subsequent studies [12e14,20]. The
reason for the increase in RDW in cardiovascular and pul-
monary diseases is not clearly understood. Nutritional de-
ficiencies, comorbid diseases, impaired renal function,
inflammatory cytokines, and erythropoiesis influenced by
neurohormonal and adrenergic system activation have been
shown to increase the level RDW [10].
In a recent study, Hampole et al showed that RDW is an
independent predictor of mortality in patients with pul-
monary hypertension due to any cause [15]. Another recent
study reports an independent association between elevated
RDW and an increased risk of acute PE-related early mor-
tality. They showed that an RDW > 14.6% on admission is
associated with an increased risk for acute PE-related early
mortality [21]. This study was conducted only in patients
with confirmed PE and it showed the importance of
increased RDW as a predictor of early mortality.
In our study, we aimed to evaluate the role of the he-
matologic parameters RDW, NLR, and PLR in the diagnostic
phase of PE. All three measures were elevated in patientswith PE but only RDW was found to be a predictor of PE
diagnosis. In contrast to the study by Fiarresga et al [22],
our study included both patients with and without a diag-
nosis of PE. We included all patients for whom PE was
included in the differential diagnosis and divided them into
two groups based on the results of thoracic computed to-
mography. This comparison is one of the strengths of this
study, making it very valuable for demonstrating the
importance of RDW in evaluating patients suspected of
having acute PE. Unfortunately, the receiver operating
characteristic analysis of RDW for predicting PE did not
adequately support the regression analysis. RDW values >
18.9 predicted PE with very high specificity but very low
sensitivity. Therefore, larger studies are needed to
demonstrate the diagnostic value of RDW for predicting PE.
In our study, we found that NLR and PLR values were
higher in the PE group than in the non-PE group. Both of these
measures are associated with inflammatory states. Recent
studies have validated the role of NLR as an independent
predictor of early mortality in various cardiovascular dis-
eases [22e24]. It has been proposed that elevated serum
cortisol levels due to increased sympathetic system activity
in acute coronary syndrome (ACS) and acute decompensated
HF may account for the alterations in neutrophil and
lymphocyte counts in these patients [25]. Moreover, it has
been proposed by some researchers that increased cytokine
release from stimulated neutrophils may be responsible for
the observed vascular injury and increased rate of intra-
coronary thrombus [26]. A recently published study also re-
ports the prognostic value of NLR in patients with acute PE.
Kayrak et al found that NLR on hospital admission may be a
predictor of 30-day mortality in acute PE [16]. In our study,
we initially demonstrated the diagnostic role of NLR in acute
PE patients. NLR levels were higher in the PE group than the
non-PE group, but in multivariate logistic regression anal-
ysis, it was shown that NLR is not a predictor for PE.
Previous studies have also shown a relationship between
high values of peripheral thrombocytes and cardiovascular
diseases. Higher platelet counts may indicate underlying
inflammation because there are several inflammatory me-
diators that stimulate megakaryocytic proliferation and
produce relative thrombocytosis. Furthermore, other
studies have shown that patients with CAD have high levels
of platelet-monocyte aggregates in their bloodstream,
which is correlated with plaque stability [17,27]. According
to these studies, we considered that there may be a rela-
tionship between PLR and PE. In fact, while PLR was found
to be elevated in patients with PE, the significance was not
supported by multivariate logistic regression analysis.
In this study, we found that both of the inflammatory
markers NLR and PLR were higher in patients with PE
compared to those without PE. We did not, however, find
NLR and PLR to be independent predictors of PE. Elevated
levels of RDW, NLR, and PLR are important criteria in the
differential diagnosis of PE, especially because they can be
measured with simple, inexpensive tests at the time of
presentation to hospital. Finally, we propose that increased
RDW values, along with troponin I and D-dimer levels, may
be used to diagnose PE.
Previous studies have also shown a relationship between
the high values of peripheral thrombocytes and cardiovascu-
lar diseases. Higher platelet counts may indicate an
Hematologic parameters in pulmonary embolism 149underlying inflammation because there are several inflam-
matory mediators that stimulate megakaryocytic prolifera-
tion and produce relative thrombocytosis. Furthermore,
other studies have shown that patients with CADs have high
levels of platelet monocyte aggregates in their bloodstream,
which is correlatedwith plaque stability [17,27]. According to
these studies, we thought that PLR may related with PE. PLR
was found to be significantly higher in PE patients but no
significance was seen in multivariate logistic regression
analysis.
In the present study we found that both NLR and PLR
were higher in PE patients than controls as inflammatory
markers. But we did not found NLR and PLR as an inde-
pendent predictor for PE. Determining RDW, NLR and PLR
can be done via easy, inexpensive tests at hospital admis-
sion. Increased levels of these three parameters were
important for diagnosis for PE. Furthermore, we think that
increased RDW values might be used to diagnose PE in
combination with troponin I and D-dimer levels.References
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